Antonella Brunello Selected Research

Antonella Brunello Research Topics

Disease

18	Neoplasms (Cancer) 05/2022 - 07/2006
13	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2016
9	Breast Neoplasms (Breast Cancer) 10/2020 - 04/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2009
3	Leiomyosarcoma 01/2022 - 03/2016
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
2	Infections 01/2022 - 01/2009
2	Epithelioid Hemangioendothelioma 01/2021 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 07/2014
2	Anemia 10/2020 - 10/2009
2	Fatigue 01/2020 - 03/2016
2	Frailty 07/2017 - 07/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	COVID-19 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Ductal Carcinoma 01/2021
1	Disease Progression 01/2021
1	Menstruation Disturbances 01/2021
1	Neurofibrosarcoma (MPNST) 01/2020
1	Vitelliform Macular Dystrophy 01/2020
1	Aggressive Fibromatosis (Desmoid) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Alopecia (Baldness) 03/2016
1	Liposarcoma 03/2016
1	Vomiting 03/2016
1	Hemangioendothelioma 01/2016
1	Pleural Effusion (Pleural Effusions) 01/2016
1	Wounds and Injuries (Trauma) 09/2014
1	Bone Fractures (Bone Fracture) 07/2012
1	Hyperglycemia 06/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2011
1	Prostatic Neoplasms (Prostate Cancer) 06/2011
1	Meningitis 01/2011
1	Osteolysis 05/2009
1	Dehydration (Water Stress) 05/2009

Drug/Important Bio-Agent (IBA)

6	AnthracyclinesIBA 12/2021 - 11/2008
5	TrabectedinIBA 01/2022 - 03/2016
4	Ifosfamide FDA LinkGeneric 12/2021 - 01/2007
4	Sunitinib (Sutent)FDA Link 01/2021 - 01/2009
4	Hormones (Hormone)IBA 04/2020 - 01/2008
3	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2008
3	Gemcitabine FDA Link 01/2020 - 11/2008
2	VaccinesIBA 01/2022 - 01/2022
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2016
2	pazopanib FDA Link 01/2021 - 01/2018
2	Tamoxifen FDA LinkGeneric 10/2020 - 04/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 09/2014 - 04/2014
2	liposomal doxorubicin (Doxil)FDA Link 10/2013 - 11/2008
2	Gefitinib (Iressa)FDA Link 01/2011 - 07/2006
2	Trastuzumab (Herceptin)FDA Link 01/2011 - 11/2008
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	avapritinibIBA 12/2021
1	ripretinibIBA 12/2021
1	multidrug resistance-associated protein 1IBA 12/2021
1	nilotinib FDA Link 12/2021
1	AZD 6244IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Transcriptional Coactivator with PDZ-Binding Motif ProteinsIBA 01/2021
1	IronIBA 10/2020
1	4-hydroxy-N-desmethyltamoxifenIBA 10/2020
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2020
1	HematinicsIBA 10/2020
1	B 43IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	AlkaloidsIBA 01/2020
1	PeriostinIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	A 17 (A-17)IBA 07/2017
1	Antineoplastic Agents (Antineoplastics)IBA 03/2016
1	1-dodecylpyridoxal (PLD)IBA 10/2013
1	Risedronic Acid (Actonel)FDA LinkGeneric 07/2012
1	Anastrozole (Arimidex)FDA LinkGeneric 07/2012
1	Rituximab (Mabthera)FDA Link 06/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011
1	Prednisone (Sone)FDA LinkGeneric 06/2011
1	SteroidsIBA 06/2011
1	Vincristine (Oncovin)FDA LinkGeneric 06/2011
1	Sorafenib (BAY 43-9006)FDA Link 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	LigandsIBA 05/2009

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
8	Therapeutics 01/2022 - 01/2008
3	Palliative Care (Palliative Therapy) 05/2022 - 01/2017
2	Ambulatory Care (Outpatient Care) 05/2022 - 05/2016
2	Radiotherapy 01/2022 - 03/2016
2	Neoadjuvant Therapy 01/2022 - 01/2020
1	Aftercare (After-Treatment) 01/2022
1	Adjuvant Radiotherapy 01/2021
1	Precision Medicine 01/2017
1	Adjuvant Chemotherapy 03/2016
1	Debridement 09/2014
1	Polypharmacy 07/2014
1	Electrodes (Electrode) 04/2014
1	Glycemic Control 06/2011